| Identification of a chlamydial protease–like activity factor responsible for the degradation of host transcription factors G Zhong, P Fan, H Ji, F Dong, Y Huang The Journal of experimental medicine 193 (8), 935-942, 2001 | 500 | 2001 |
| Degradation of transcription factor Rfx5 during the inhibition of both constitutive and interferon γ–inducible major histocompatibility complex class I expression in chlamydia … G Zhong, LI Liu, T Fan, P Fan, H Ji The Journal of experimental medicine 191 (9), 1525-1534, 2000 | 269 | 2000 |
| Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers TB Ball, H Ji, J Kimani, P McLaren, C Marlin, AVS Hill, FA Plummer Aids 21 (9), 1091-1101, 2007 | 118 | 2007 |
| Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey S Ávila-Ríos, C García-Morales, M Matías-Florentino, KA Romero-Mora, ... The lancet HIV 3 (12), e579-e591, 2016 | 108 | 2016 |
| Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR–/–mouse model within six months L Liu, H Hu, H Ji, AD Murdin, GN Pierce, G Zhong Molecular and cellular biochemistry 215, 123-128, 2000 | 76 | 2000 |
| A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1 B Liang, M Luo, J Scott-Herridge, C Semeniuk, M Mendoza, R Capina, ... PloS one 6 (10), e26745, 2011 | 68 | 2011 |
| Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination A Ssemaganda, HM Nguyen, F Nuhu, N Jahan, CM Card, S Kiazyk, ... Nature communications 13 (1), 3357, 2022 | 58 | 2022 |
| Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing ER Lee, N Parkin, C Jennings, CJ Brumme, E Enns, M Casadellà, ... Scientific Reports 10 (1), 1634, 2020 | 56 | 2020 |
| Next-generation sequencing for HIV drug resistance testing: laboratory, clinical, and implementation considerations S Ávila-Ríos, N Parkin, R Swanstrom, R Paredes, R Shafer, H Ji, R Kantor Viruses 12 (6), 617, 2020 | 55 | 2020 |
| HIV drug resistance surveillance using pooled pyrosequencing H Ji, N Massé, S Tyler, B Liang, Y Li, H Merks, M Graham, P Sandstrom, ... PloS one 5 (2), e9263, 2010 | 48 | 2010 |
| Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations H Ji, RA Kozak, MJ Biondi, R Pilon, D Vallee, BB Liang, D La, J Kim, ... Virology 477, 1-9, 2015 | 47 | 2015 |
| Multi-laboratory comparison of next-generation to sanger-based sequencing for HIV-1 drug resistance genotyping NT Parkin, S Avila-Rios, DF Bibby, CJ Brumme, SH Eshleman, ... Viruses 12 (7), 694, 2020 | 42 | 2020 |
| Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg consensus H Ji, E Enns, CJ Brumme, N Parkin, M Howison, ER Lee, R Capina, ... Journal of the International AIDS Society 21 (10), e25193, 2018 | 42 | 2018 |
| A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance T Taylor, ER Lee, M Nykoluk, E Enns, B Liang, R Capina, MK Gauthier, ... Scientific Reports 9 (1), 8970, 2019 | 41 | 2019 |
| Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance H Ji, Y Li, M Graham, BB Liang, R Pilon, S Tyson, G Peters, S Tyler, ... Antiviral therapy 16 (6), 871-878, 2011 | 38 | 2011 |
| Are we ready for NGS HIV drug resistance testing? The second “winnipeg consensus” symposium H Ji, P Sandstrom, R Paredes, PR Harrigan, CJ Brumme, S Avila Rios, ... Viruses 12 (6), 586, 2020 | 31 | 2020 |
| Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by … H Ji, TB Ball, Z Ao, J Kimani, X Yao, FA Plummer Scandinavian journal of infectious diseases 42 (5), 389-394, 2010 | 25 | 2010 |
| Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing H Ji, TB Ball, J Kimani, FA Plummer Journal of human genetics 49 (10), 528-535, 2004 | 21 | 2004 |
| Prevalence of primary drug resistance against HIV-1 integrase inhibitors in Canada H Ji, A Patterson, T Taylor, C Rank, J Halverson, R Capina, J Brooks, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 78 (1), e1-e3, 2018 | 19 | 2018 |
| External quality assessment for next-generation sequencing-based HIV drug resistance testing: Unique requirements and challenges ER Lee, F Gao, P Sandstrom, H Ji Viruses 12 (5), 550, 2020 | 16 | 2020 |
